Bernstein Liebhard LLP is investigating whether the Board of Directors of Gerber Scientific, Inc. (“Gerber Scientific” or the “Company”) (NYSE: GRB) breached its fiduciary duty to its shareholders in agreeing to sell Gerber Scientific to funds affiliated with Vector Capital Corporation. Under the terms of the agreement, Gerber Scientific shareholders will receive $11.00 in cash for each share they own. The investigation is focused on the potential unfairness of the price to Gerber Scientific shareholders and the process by which the Gerber Scientific Board of Directors considered and approved the transaction. If you are interested in discussing your rights as a Gerber Scientific shareholder and/or have information relating to the matter, please contact U. Seth Ottensoser at (877) 779-1414 or Ottensoser@bernlieb.com. Bernstein Liebhard has pursued hundreds of securities, consumer and shareholder rights cases and recovered almost $3 billion for its clients. It has been named to The National Law Journal’s “Plaintiffs’ Hot List” in each of the last eight years.
Bernstein Liebhard LLP10 East 40th Street New York, New York 10016(877) 779-1414 www.bernlieb.com
Gerber Scientific (NYSE:GRB) hit a new 52-week high Friday as it is currently trading at $11.18, above its previous 52-week high of $11.15 with 9,721 shares traded as of 10:16 a.m. ET. Average volume has been 492,800 shares over the past 30 days.
Shares of Gerber Scientific (NYSE:GRB) have taken a tremendous swing upward. The stock is trading at $10.87 as of 9:31 a.m. ET, 33.9% above Friday's closing price of $8.12. Volume is at 11.6 million, 217.1 times the daily average of 53,200.
Shares of Gerber Scientific (NYSE:GRB) have taken a tremendous swing upward. The stock is trading at $9.47 as of 9:56 a.m. ET, 20.9% above Wednesday's closing price of $7.83. Volume is at 27,319, 0.4 times the daily average of 61,900.